DCA seizes syrup stocks over misleading fever cure claim

Officials from the Telangana Drugs Control Administration (DCA) have seized stocks of a syrup marketed as a cure for ‘all types of fevers’, citing violation of the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954.

During a raid conducted on May 14 at a medical store in Adilabad, the DCA officers found the product, ‘Herbal Fever Guard Syrup’ being sold with a label that falsely claimed it could treat all types of fevers. The medicine is manufactured and marketed by International Herbal Corporation Private Limited, based in Haridwar, Uttarakhand, said a release.

Authorities said the product’s label amounts to a misleading advertisement, which is prohibited under the 1954 Act. The law explicitly bans advertisements that promote medicines as treatments for certain diseases and conditions, including fevers in general. As per the Act, no person is allowed to participate in the publication or circulation of such advertisements.

Stocks of the syrup were seized on the spot, and further investigation is underway, the release stated.

Related Posts

Mankind Pharma to Acquire 70% Stake in Belgium’s ACTx

Shares of Mankind Pharma fell more than 2% on 16 October after the company announced that it has signed an agreement to acquire a 70% stake in Belgium-based biotechnology company…

Can a drug licence be suspended before a hearing? Karnataka HC explains rule

NEW DELHI: Can a drug licensing authority suspend a pharmaceutical distributor’s licence while issuing a show-cause notice, before considering its response? The Karnataka high court has said the procedure under…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Mankind Pharma to Acquire 70% Stake in Belgium’s ACTx

Mankind Pharma to Acquire 70% Stake in Belgium’s ACTx

Can a drug licence be suspended before a hearing? Karnataka HC explains rule

Can a drug licence be suspended before a hearing? Karnataka HC explains rule

A Boy survives 18th Floor Fall, thanks to Yashoda Medicity

A Boy survives 18th Floor Fall, thanks to Yashoda Medicity

AstraZeneca, NIPER Raebareli partner to upgrade 25 clinical trail sites

AstraZeneca, NIPER Raebareli partner to upgrade 25 clinical trail sites

FDA clears ImmunityBio’s Anktiva expansion in bladder cancer after regulatory whiplash

FDA clears ImmunityBio’s Anktiva expansion in bladder cancer after regulatory whiplash

Sun Pharma Approves Rs 10,000 Crore Fundraising Through NCDs

Sun Pharma Approves Rs 10,000 Crore Fundraising Through NCDs